The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antidiuretic Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Antidiuretic substance helps to control the fluid balance in the body. Their action is opposite to that of diuretics which disrupt this balance. Major antidiuretic drugs are vasopressin (also known as antidiuretic hormone (ADH)), desmopressin, and oxytocin. In diabetes insipidus, antidiuretic drugs reduce the urine volume.
The global Antidiuretic Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antidiuretic Drugs in various end use industries. The expanding demands from the Diabetes Insipidus, Hemophilia, Hypertension and Others, are propelling Antidiuretic Drugs market. Vasopressin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Desmopressin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antidiuretic Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antidiuretic Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antidiuretic Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antidiuretic Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antidiuretic Drugs covered in this report include Par Sterile Products, ADH Health, Azevan Pharmaceuticals, Teva Pharmaceutical, Otsuka Holdings, Taj Pharmaceuticals and ALLERGAN, etc.
The global Antidiuretic Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Par Sterile Products
ADH Health
Azevan Pharmaceuticals
Teva Pharmaceutical
Otsuka Holdings
Taj Pharmaceuticals
ALLERGAN
Global Antidiuretic Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antidiuretic Drugs market, Segment by Type:
Vasopressin
Desmopressin
Oxytocin
Others
Global Antidiuretic Drugs market, by Application
Diabetes Insipidus
Hemophilia
Hypertension
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antidiuretic Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antidiuretic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Antidiuretic substance helps to control the fluid balance in the body. Their action is opposite to that of diuretics which disrupt this balance. Major antidiuretic drugs are vasopressin (also known as antidiuretic hormone (ADH)), desmopressin, and oxytocin. In diabetes insipidus, antidiuretic drugs reduce the urine volume.
The global Antidiuretic Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antidiuretic Drugs in various end use industries. The expanding demands from the Diabetes Insipidus, Hemophilia, Hypertension and Others, are propelling Antidiuretic Drugs market. Vasopressin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Desmopressin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antidiuretic Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antidiuretic Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antidiuretic Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antidiuretic Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antidiuretic Drugs covered in this report include Par Sterile Products, ADH Health, Azevan Pharmaceuticals, Teva Pharmaceutical, Otsuka Holdings, Taj Pharmaceuticals and ALLERGAN, etc.
The global Antidiuretic Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Par Sterile Products
ADH Health
Azevan Pharmaceuticals
Teva Pharmaceutical
Otsuka Holdings
Taj Pharmaceuticals
ALLERGAN
Global Antidiuretic Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antidiuretic Drugs market, Segment by Type:
Vasopressin
Desmopressin
Oxytocin
Others
Global Antidiuretic Drugs market, by Application
Diabetes Insipidus
Hemophilia
Hypertension
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antidiuretic Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antidiuretic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antidiuretic Drugs Market Overview
1.1 Antidiuretic Drugs Product Overview
1.2 Antidiuretic Drugs Market Segment by Type
1.2.1 Vasopressin
1.2.2 Desmopressin
1.2.3 Oxytocin
1.2.4 Others
1.3 Global Antidiuretic Drugs Market Size by Type
1.3.1 Global Antidiuretic Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Antidiuretic Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antidiuretic Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antidiuretic Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antidiuretic Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antidiuretic Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antidiuretic Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antidiuretic Drugs Sales Breakdown by Type (2018-2023)
2 Global Antidiuretic Drugs Market Competition by Company
2.1 Global Top Players by Antidiuretic Drugs Sales (2018-2023)
2.2 Global Top Players by Antidiuretic Drugs Revenue (2018-2023)
2.3 Global Top Players by Antidiuretic Drugs Price (2018-2023)
2.4 Global Top Manufacturers Antidiuretic Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antidiuretic Drugs Market Competitive Situation and Trends
2.5.1 Antidiuretic Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antidiuretic Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antidiuretic Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Antidiuretic Drugs Market
2.8 Key Manufacturers Antidiuretic Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antidiuretic Drugs Status and Outlook by Region
3.1 Global Antidiuretic Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antidiuretic Drugs Historic Market Size by Region
3.2.1 Global Antidiuretic Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Antidiuretic Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Antidiuretic Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antidiuretic Drugs Forecasted Market Size by Region
3.3.1 Global Antidiuretic Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Antidiuretic Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Antidiuretic Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antidiuretic Drugs by Application
4.1 Antidiuretic Drugs Market Segment by Application
4.1.1 Diabetes Insipidus
4.1.2 Hemophilia
4.1.3 Hypertension
4.1.4 Others
4.2 Global Antidiuretic Drugs Market Size by Application
4.2.1 Global Antidiuretic Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Antidiuretic Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antidiuretic Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antidiuretic Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antidiuretic Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antidiuretic Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antidiuretic Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antidiuretic Drugs Sales Breakdown by Application (2018-2023)
5 North America Antidiuretic Drugs by Country
5.1 North America Antidiuretic Drugs Historic Market Size by Country
5.1.1 North America Antidiuretic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antidiuretic Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Antidiuretic Drugs Sales in Value by Country (2018-2023)
5.2 North America Antidiuretic Drugs Forecasted Market Size by Country
5.2.1 North America Antidiuretic Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Antidiuretic Drugs Sales in Value by Country (2024-2029)
6 Europe Antidiuretic Drugs by Country
6.1 Europe Antidiuretic Drugs Historic Market Size by Country
6.1.1 Europe Antidiuretic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antidiuretic Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Antidiuretic Drugs Sales in Value by Country (2018-2023)
6.2 Europe Antidiuretic Drugs Forecasted Market Size by Country
6.2.1 Europe Antidiuretic Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Antidiuretic Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Antidiuretic Drugs by Region
7.1 Asia-Pacific Antidiuretic Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Antidiuretic Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antidiuretic Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antidiuretic Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antidiuretic Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Antidiuretic Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antidiuretic Drugs Sales in Value by Region (2024-2029)
8 Latin America Antidiuretic Drugs by Country
8.1 Latin America Antidiuretic Drugs Historic Market Size by Country
8.1.1 Latin America Antidiuretic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antidiuretic Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antidiuretic Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Antidiuretic Drugs Forecasted Market Size by Country
8.2.1 Latin America Antidiuretic Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antidiuretic Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Antidiuretic Drugs by Country
9.1 Middle East and Africa Antidiuretic Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Antidiuretic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antidiuretic Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antidiuretic Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antidiuretic Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Antidiuretic Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antidiuretic Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Par Sterile Products
10.1.1 Par Sterile Products Company Information
10.1.2 Par Sterile Products Introduction and Business Overview
10.1.3 Par Sterile Products Antidiuretic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Par Sterile Products Antidiuretic Drugs Products Offered
10.1.5 Par Sterile Products Recent Development
10.2 ADH Health
10.2.1 ADH Health Company Information
10.2.2 ADH Health Introduction and Business Overview
10.2.3 ADH Health Antidiuretic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 ADH Health Antidiuretic Drugs Products Offered
10.2.5 ADH Health Recent Development
10.3 Azevan Pharmaceuticals
10.3.1 Azevan Pharmaceuticals Company Information
10.3.2 Azevan Pharmaceuticals Introduction and Business Overview
10.3.3 Azevan Pharmaceuticals Antidiuretic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Azevan Pharmaceuticals Antidiuretic Drugs Products Offered
10.3.5 Azevan Pharmaceuticals Recent Development
10.4 Teva Pharmaceutical
10.4.1 Teva Pharmaceutical Company Information
10.4.2 Teva Pharmaceutical Introduction and Business Overview
10.4.3 Teva Pharmaceutical Antidiuretic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva Pharmaceutical Antidiuretic Drugs Products Offered
10.4.5 Teva Pharmaceutical Recent Development
10.5 Otsuka Holdings
10.5.1 Otsuka Holdings Company Information
10.5.2 Otsuka Holdings Introduction and Business Overview
10.5.3 Otsuka Holdings Antidiuretic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Otsuka Holdings Antidiuretic Drugs Products Offered
10.5.5 Otsuka Holdings Recent Development
10.6 Taj Pharmaceuticals
10.6.1 Taj Pharmaceuticals Company Information
10.6.2 Taj Pharmaceuticals Introduction and Business Overview
10.6.3 Taj Pharmaceuticals Antidiuretic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Taj Pharmaceuticals Antidiuretic Drugs Products Offered
10.6.5 Taj Pharmaceuticals Recent Development
10.7 ALLERGAN
10.7.1 ALLERGAN Company Information
10.7.2 ALLERGAN Introduction and Business Overview
10.7.3 ALLERGAN Antidiuretic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 ALLERGAN Antidiuretic Drugs Products Offered
10.7.5 ALLERGAN Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antidiuretic Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antidiuretic Drugs Industrial Chain Analysis
11.4 Antidiuretic Drugs Market Dynamics
11.4.1 Antidiuretic Drugs Industry Trends
11.4.2 Antidiuretic Drugs Market Drivers
11.4.3 Antidiuretic Drugs Market Challenges
11.4.4 Antidiuretic Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antidiuretic Drugs Distributors
12.3 Antidiuretic Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
